Zanon E - Search Results

1

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.

Peyvandi F, Mannucci PM, Garagiola I, El-Beshlawy A, Elalfy M, Ramanan V, Eshghi P, Hanagavadi S, Varadarajan R, Karimi M, Manglani MV, Ross C, Young G, Seth T, Apte S, Nayak DM, Santagostino E, Mancuso ME, Sandoval Gonzalez AC, Mahlangu JN, Bonanad Boix S, Cerqueira M, Ewing NP, Male C, Owaidah T, Soto Arellano V, Kobrinsky NL, Majumdar S, Perez Garrido R, Sachdeva A, Simpson M, Thomas M, Zanon E, Antmen B, Kavakli K, Manco-Johnson MJ, Martinez M, Marzouka E, Mazzucconi MG, Neme D, Palomo Bravo A, Paredes Aguilera R, Prezotti A, Schmitt K, Wicklund BM, Zulfikar B, Rosendaal FR. Peyvandi F, et al. Among authors: zanon e. N Engl J Med. 2016 May 26;374(21):2054-64. doi: 10.1056/NEJMoa1516437. N Engl J Med. 2016. PMID: 27223147 Free article. Clinical Trial.

2

Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity.

Vianello F, Tison T, Tagariello G, Zerbinati P, Zanon E, Scarano L, Girolami A. Vianello F, et al. Among authors: zanon e. Blood Coagul Fibrinolysis. 1999 Sep;10(6):393-7. Blood Coagul Fibrinolysis. 1999. PMID: 10493222

3

Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gastrointestinal bleeding in patients with von Willebrand type III disease.

Zanon E, Vianello F, Casonato A, Girolami A. Zanon E, et al. Haemophilia. 2001 Sep;7(5):500-3. doi: 10.1046/j.1365-2516.2001.00543.x. Haemophilia. 2001. PMID: 11554939

4

Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis.

Bilora F, Boccioletti V, Zanon E, Petrobelli F, Girolami A. Bilora F, et al. Among authors: zanon e. Clin Appl Thromb Hemost. 2001 Oct;7(4):311-3. doi: 10.1177/107602960100700411. Clin Appl Thromb Hemost. 2001. PMID: 11697715 Free article.

5

Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases.

Girolami A, Scandellari R, Zanon E, Sartori R, Girolami B. Girolami A, et al. Among authors: zanon e. J Thromb Thrombolysis. 2006 Jun;21(3):279-84. doi: 10.1007/s11239-006-6556-7. J Thromb Thrombolysis. 2006. PMID: 16683222 Review.

6

Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.

Federici AB, Castaman G, Franchini M, Morfini M, Zanon E, Coppola A, Tagliaferri A, Boeri E, Mazzucconi MG, Rossetti G, Mannucci PM. Federici AB, et al. Among authors: zanon e. Haematologica. 2007 Jul;92(7):944-51. doi: 10.3324/haematol.11124. Haematologica. 2007. PMID: 17606445 Free article.

7

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype.

Margaglione M, Castaman G, Morfini M, Rocino A, Santagostino E, Tagariello G, Tagliaferri AR, Zanon E, Bicocchi MP, Castaldo G, Peyvandi F, Santacroce R, Torricelli F, Grandone E, Mannucci PM; AICE-Genetics Study Group. Margaglione M, et al. Among authors: zanon e. Haematologica. 2008 May;93(5):722-8. doi: 10.3324/haematol.12427. Epub 2008 Apr 2. Haematologica. 2008. PMID: 18387975 Free article.

8

Evidence-based recommendations on the treatment of von Willebrand disease in Italy.

Mannucci PM, Franchini M, Castaman G, Federici AB; Italian Association of Hemophilia Centers. Mannucci PM, et al. Blood Transfus. 2009 Apr;7(2):117-26. doi: 10.2450/2008.0052-08. Blood Transfus. 2009. PMID: 19503633 Free PMC article.

9

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.

Coppola A, Margaglione M, Santagostino E, Rocino A, Grandone E, Mannucci PM, Di Minno G; AICE PROFIT Study Group. Coppola A, et al. J Thromb Haemost. 2009 Nov;7(11):1809-15. doi: 10.1111/j.1538-7836.2009.03615.x. Epub 2009 Sep 9. J Thromb Haemost. 2009. PMID: 19740093 Free article.

10

Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score.

Federici AB, Barillari G, Zanon E, Mazzucconi MG, Musso R, Targhetta R, Mannucci PM. Federici AB, et al. Among authors: zanon e. Haemophilia. 2010 Jan;16(1):101-10. doi: 10.1111/j.1365-2516.2009.02088.x. Epub 2009 Oct 6. Haemophilia. 2010. PMID: 19811543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page